Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Probable G-protein coupled receptor 141 (GPR141) is an orphan Class A (rhodopsin-like) G protein-coupled receptor encoded by the GPR141 gene in humans[3][4][6]. Highly expressed in myeloid-lineage cells such as neutrophils, monocytes, macrophages, and dendritic cells, GPR141 functions as a negative regulator of immune responses and inflammation, notably by suppressing excessive myeloid cell activation[1]. Recent research indicates GPR141 is a promoter of breast cancer proliferation, migration, and epithelial to mesenchymal transition by modulating p53 and mTOR1 signaling and influencing the tumor microenvironment[2][4]. Although not yet targeted by approved drugs, GPR141 is under investigation as a potential therapeutic target for both cancer and immune-mediated disorders.
No approved drugs; mechanism of action inferred from gene/protein modulation studies—e.g., GPR141 knockdown impedes breast cancer proliferation through p53 restoration and mTOR1 pathway attenuation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable G-protein coupled receptor 141 (GPR141).